25 related articles for article (PubMed ID: 15650031)
1. Determining Plasma Tacrolimus Concentrations Using High-Performance LC-MS/MS in Renal Transplant Recipients.
Alonge M; Coller JK; Reuter SE; Jesudason S; Sallustio BC
Ther Drug Monit; 2024 Feb; 46(1):49-56. PubMed ID: 38193880
[TBL] [Abstract][Full Text] [Related]
2. Tacrolimus Monitoring in Liver Transplant Recipients, Posttransplant Cholestasis: A Comparative Between 2 Commercial Immunoassays and a Liquid Chromatography-Tandem Mass Spectrometry Method.
Parant F; Delignette MC; Charpiat B; Lacaille L; Lebosse F; Monneret G; Mohkam K; Mabrut JY; Aubrun F; Heyer L; Antonini T
Ther Drug Monit; 2024 Apr; ():. PubMed ID: 38648663
[TBL] [Abstract][Full Text] [Related]
3. Tacrolimus monitoring in hair samples of kidney transplant recipients.
Born A; Bocchi F; Kuhn C; Amstutz U; Baumgartner MR; Sidler D
Front Med (Lausanne); 2023; 10():1307505. PubMed ID: 38111700
[TBL] [Abstract][Full Text] [Related]
4. Tacrolimus Concentration Is Effectively Predicted Using Combined Clinical and Genetic Factors in the Perioperative Period of Kidney Transplantation and Associated with Acute Rejection.
Cheng F; Li Q; Cui Z; Wang Z; Zeng F; Zhang Y
J Immunol Res; 2022; 2022():3129389. PubMed ID: 36118414
[TBL] [Abstract][Full Text] [Related]
5. Genetic Polymorphisms Affecting Tacrolimus Metabolism and the Relationship to Post-Transplant Outcomes in Kidney Transplant Recipients.
Cheng F; Li Q; Wang J; Hu M; Zeng F; Wang Z; Zhang Y
Pharmgenomics Pers Med; 2021; 14():1463-1474. PubMed ID: 34824543
[TBL] [Abstract][Full Text] [Related]
6. Tacrolimus trough monitoring guided by mass spectrometry without accounting for assay differences is associated with acute kidney injury in lung transplant recipients.
Kolaitis NA; Calabrese DR; Ahearn P; Venado A; Florez R; Lei HL; Isaak K; Henricksen E; Martinez E; Chong T; Shah RJ; Leard LE; Kleinhenz ME; Golden J; De Marco T; Greenland JR; Kukreja J; Hays SR; Blanc PD; Singer JP
Am J Health Syst Pharm; 2019 Dec; 76(24):2019-2027. PubMed ID: 31696925
[TBL] [Abstract][Full Text] [Related]
7. Higher tacrolimus concentrations early after transplant reduce the risk of acute GvHD in reduced-intensity allogeneic stem cell transplantation.
Ganetsky A; Shah A; Miano TA; Hwang WT; He J; Loren AW; Hexner EO; Frey NV; Porter DL; Reshef R
Bone Marrow Transplant; 2016 Apr; 51(4):568-72. PubMed ID: 26691423
[TBL] [Abstract][Full Text] [Related]
8. The use of a DNA biobank linked to electronic medical records to characterize pharmacogenomic predictors of tacrolimus dose requirement in kidney transplant recipients.
Birdwell KA; Grady B; Choi L; Xu H; Bian A; Denny JC; Jiang M; Vranic G; Basford M; Cowan JD; Richardson DM; Robinson MP; Ikizler TA; Ritchie MD; Stein CM; Haas DW
Pharmacogenet Genomics; 2012 Jan; 22(1):32-42. PubMed ID: 22108237
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic optimization of immunosuppressive therapy in thoracic transplantation: part I.
Monchaud C; Marquet P
Clin Pharmacokinet; 2009; 48(7):419-62. PubMed ID: 19691367
[TBL] [Abstract][Full Text] [Related]
10. Modified pentamer formation assay for measurement of tacrolimus and its active metabolites: comparison with liquid chromatography-tandem mass spectrometry and microparticle enzyme-linked immunoassay (MEIA-II).
Armstrong VW; Schuetz E; Zhang Q; Groothuisen S; Scholz C; Shipkova M; Aboleneen H; Oellerich M
Clin Chem; 1998 Dec; 44(12):2516-23. PubMed ID: 9836720
[TBL] [Abstract][Full Text] [Related]
11. An immunophilin-binding assay for sirolimus.
Davis DL; Soldin SJ
Clin Ther; 2000; 22 Suppl B():B62-70. PubMed ID: 10823374
[TBL] [Abstract][Full Text] [Related]
12. Low hematocrit and serum albumin concentrations underlie the overestimation of tacrolimus concentrations by microparticle enzyme immunoassay versus liquid chromatography-tandem mass spectrometry.
Brown NW; Gonde CE; Adams JE; Tredger JM
Clin Chem; 2005 Mar; 51(3):586-92. PubMed ID: 15650031
[TBL] [Abstract][Full Text] [Related]
13. Is microparticle enzyme-linked immunoassay (MEIA) reliable for use in tacrolimus TDM? Comparison of MEIA to liquid chromatography with mass spectrometric detection using longitudinal trough samples from transplant recipients.
Napoli KL
Ther Drug Monit; 2006 Aug; 28(4):491-504. PubMed ID: 16885716
[TBL] [Abstract][Full Text] [Related]
14. Is the affinity column-mediated immunoassay method suitable as an alternative to the microparticle enzyme immunoassay method as a blood tacrolimus assay?
Ju MK; Chang HK; Kim HJ; Huh KH; Ahn HJ; Kim MS; Kim SI; Kim YS
Transplant Proc; 2008 Dec; 40(10):3673-8. PubMed ID: 19100463
[TBL] [Abstract][Full Text] [Related]
15. Cloned enzyme donor immunoassay tacrolimus assay compared with high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in liver and renal transplant recipients.
Westley IS; Taylor PJ; Salm P; Morris RG
Ther Drug Monit; 2007 Oct; 29(5):584-91. PubMed ID: 17898648
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
